Polycystic ovary syndrome: Brain-derived neurotrophic factor (BDNF) plasma and follicular fluid levels

Gynecological Endocrinology

Volumn 28, Issue 4, 2012, Pages 241-244

  Russo, N ^a   Russo, M ^a   Daino, D ^a   Bucci, F ^a   Pluchino, N ^a   Casarosa, E ^a   Artini, P G ^a   Cela, V ^a   Luisi, M ^a   Genazzani, A R ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

BDNF; Follicular fluid; Gonadotropins; PCOS; Plasma

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; ADOLESCENT; BLOOD; METABOLISM; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICULAR FLUID; HUMANS; LUTEINIZING HORMONE; POLYCYSTIC OVARY SYNDROME; PROGESTERONE; YOUNG ADULT;

EID: 84858402323     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.613969     Document Type: Article

References (34)

1. Yen and Jaffe's reproductive endocrinology: Physiology, pathophysiology, and clinical management. Elsevier Health Sciences 2009.
2. Cussons AJ, Stuckey BG, Walsh JP, Burke V, Norman RJ. Polycystic ovarian syndrome: Marked differences between endocrinologists and gynaecologists in diagnosis and management. Clin Endocrinol (Oxf) 2005;62:289-295.
3. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risk related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
4. Lobo RA, Kletzky OA, Campeau JD, diZerega GS. Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome. Fertil Steril 1983;39:674-678.
5. Nelson VL, Qin KN, Rosenfield RL, Wood JR, Penning TM, Legro RS, Strauss JF 3rd, McAllister JM. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86:5925-5933.
6. Nelson VL, Legro RS, Strauss JF 3rd, McAllister JM. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 1999;13:946-957.
7. Azziz R. Controversy in clinical endocrinology: Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature. J Clin Endocrinol Metab 2006;91:781-785.
8. Hughesdon PE. Morphology and morphogenesis of the Stein- Leventhal ovary and of so-called "hyperthecosis". Obstet Gynecol Surv 1982;37:59-77.
9. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, Franks S. Formation and early development of follicles in the polycystic ovary. Lancet 2003;362:1017-1021.
10. Monteleone P, Artini PG, Simi G, Cela V, Casarosa E, Begliuomini S, Ninni F, et al. Brain derived neurotrophic factor circulating levels in patients undergoing IVF. J Assist Reprod Genet 2007;24:477-480.
11. Seifer DB, Feng B, Shelden RM. Immunocytochemical evidence for the presence and location of the neurotrophin-Trk receptor family in adult human preovulatory ovarian follicles. Am J Obstet Gynecol 2006;194:1129-34; discussion 1134.
12. Ojeda SR, Romero C, Tapia V, Dissen GA. Neurotrophic and cell-cell dependent control of early follicular development. Mol Cell Endocrinol 2000;163:67-71.
13. Seifer DB, Feng B, Shelden RM, Chen S, Dreyfus CF. Neurotrophin-4/5 and neurotrophin-3 are present within the human ovarian follicle but appear to have different paracrine/autocrine functions. J Clin Endocrinol Metab 2002;87:4569-4571.
14. Seifer DB, Feng B, Shelden RM, Chen S, Dreyfus CF. Brain-derived neurotrophic factor: A novel human ovarian follicular protein. J Clin Endocrinol Metab 2002;87:655-659.
15. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998;37:1553-1561.
16. Seifer DB, Lambert-Messerlian G, Schneyer AL. Ovarian brain-derived neurotrophic factor is present in follicular fluid from normally cycling women. Fertil Steril 2003;79:451-452.
17. Barde YA. The nerve growth factor family. Prog Growth Factor Res 1990;2:237-248.
18. Sohrabji F, Miranda RC, Toran-Allerand CD. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci USA 1995;92:11110-11114.
19. Begliuomini S, Casarosa E, Pluchino N, Lenzi E, Centofanti M, Freschi L, Pieri M, et al. Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod 2007;22:995-1002.
20. Poduslo JF, Curran GL. Permeability at the blood-brain and bloodnerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res 1996;36:280-286.
21. Cubeddu A, Giannini A, Bucci F, Merlini S, Casarosa E, Pluchino N, Luisi S, et al. Paroxetine increases brain-derived neurotrophic factor in postmenopausal women. Menopause 2010;17:338-343.
22. Cubeddu A, Bucci F, Giannini A, Russo M, Daino D, Russo N, Merlini S, et al. Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology 2011;36:523-530.
23. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, Virchow JC. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005;26:115-123.
24. Harel S, Jin S, Fisch B, Feldberg D, Krissi H, Felz C, Freimann S, et al. Tyrosine kinase B receptor and its activated neurotrophins in ovaries from human fetuses and adults. Mol Hum Reprod 2006;12:357-365.
25. Anger DL, Zhang B, Boutross-Tadross O, Foster WG. Tyrosine receptor kinase B (TrkB) protein expression in the human endometrium. Endocrine 2007;31:167-173.
26. Givens JR. Ovarian hyperthecosis. N Engl J Med 1971;285:691.
27. Lunde O, Magnus P, Sandvik L, Høglo S. Familial clustering in the polycystic ovarian syndrome. Gynecol Obstet Invest 1989;28: 23-30.
28. Hickey TE, Legro RS, Norman RJ. Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:2789-2791.
29. Davies MJ, Norman RJ. Programming and reproductive functioning. Trends Endocrinol Metab 2002;13:386-392.
30. Azziz R, Kashar-Miller MD. Family history as a risk factor for the polycystic ovary syndrome. J Pediatr Endocrinol Metab 2000;13 Suppl 5:1303-1306.
31. Kahsar-Miller MD, Nixon C, Boots LR, Go RC, Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 2001;75:53-58.
32. Giudice LC, Cataldo NA, van Dessel HJ, Yap OW, Chandrasekher YA. Growth factors in normal ovarian follicle development. Semin Reprod Endocrinol 1996;14:179-196.
33. Haisenleder DJ, Dalkin AC, Ortolano GA, Marshall JC, Shupnik MA. A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes: Evidence for differential regulation of transcription by pulse frequency in vivo. Endocrinology 1991;128:509-517.
34. Paredes A, Romero C, Dissen GA, DeChiara TM, Reichardt L, Cornea A, Ojeda SR, Xu B. TrkB receptors are required for follicular growth and oocyte survival in the mammalian ovary. Dev Biol 2004;267:430-449.